Pharmaceutical Business Go-To Market | PART 5 | Demystifying Pharma скачать в хорошем качестве

Pharmaceutical Business Go-To Market | PART 5 | Demystifying Pharma

Explore the biggest players in the global pharmaceutical landscape as we break down the key markets shaping the future of healthcare. The United States remains the leader with its $500 billion market, which nearly accounts for half of the world's revenue. We will explore how the US FDA's approval process can determine the fate of pharma companies. We will also examine why the US market plays such a decisive factor in drug prices and innovation. Next, we focus on China, a rapidly growing market expected to overtake the United States within the next decade. This growth is due to its massive population and increasing demand for healthcare, as the median age of the population rises. However, China's protective policies pose challenges for international companies attempting to penetrate its market, and they prevent local consumers from accessing the world’s most innovative drugs. In the next part of the video, we focus on India. Although it has a smaller domestic market, it stands as a global powerhouse in drug manufacturing, particularly for generic drugs and vaccines. Additionally, India is home to over 20% of US FDA-approved drug sites, making it a critical player in the global pharmaceutical supply chain. Finally, we touch on the challenges that pharmaceutical companies face with B2B sales models, access to patient data, and marketing in a world increasingly driven by data and direct-to-consumer interactions. If you enjoyed this video on the interactions and competition within the global pharmaceutical market, we encourage you to subscribe to our channel and click the bell icon for more insights into the evolving pharmaceutical industry. 📢 Stay Connected! ✅ Subscribe our channel for more research insights ✅ Like & Share our videos to support scientific advancements ✅ Learn more at https://www.aurigeneservices.com/